{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:44:23Z","timestamp":1791398663966,"version":"4.3.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T00:00:00Z","timestamp":1418342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00404-014-3581-1","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T12:29:03Z","timestamp":1418300943000},"page":"969-975","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The use of intravenous magnesium in non-preeclamptic pregnant women: fetal\/neonatal neuroprotection"],"prefix":"10.1007","volume":"291","author":[{"given":"Y.","family":"Jacquemyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Zecic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Van Laere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Roelens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,12]]},"reference":[{"key":"3581_CR1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1056\/NEJMoa0706475","volume":"359","author":"D Moster","year":"2008","unstructured":"Moster D, Lie RT, Markestad T (2008) Long-term medical and social consequences of preterm birth. N Engl J Med 359:262\u2013273","journal-title":"N Engl J Med"},{"key":"3581_CR2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1542\/peds.95.2.263","volume":"95","author":"KB Nelson","year":"1995","unstructured":"Nelson KB, Grether JK (1995) Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants. Pediatrics 95:263\u2013269","journal-title":"Pediatrics"},{"key":"3581_CR3","first-page":"36","volume":"5","author":"Y Jacquemyn","year":"2010","unstructured":"Jacquemyn Y (2010) Use of tocolytics and birth outcome. Eur Obstet Gynaecol 5:36\u201338","journal-title":"Eur Obstet Gynaecol"},{"key":"3581_CR4","doi-asserted-by":"crossref","unstructured":"Crowther CA, Brown J, McKinlay CJ, Middleton P (2002) Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev (8):CD001060. doi: 10.1002\/14651858.CD001060.pub2","DOI":"10.1002\/14651858.CD001060.pub2"},{"key":"3581_CR5","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1067\/mob.2002.123544","volume":"186","author":"R Mittendorf","year":"2002","unstructured":"Mittendorf R, Dambrosia J, Pryde PG, Lee KS, Gianapoulos JG, Besinger RE et al (2002) Association between the use of antenatal magnesium sulphate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 186:1111\u20131118","journal-title":"Am J Obstet Gynecol"},{"key":"3581_CR6","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.gyobfe.2008.01.012","volume":"36","author":"S Marret","year":"2008","unstructured":"Marret S, Marpeau L, Follet-Bouhamed C (2008) Effect of magnesium sulfate on mortality and neurologic morbidity of the very-preterm newborn with two-year neurologic outcome: results of the prospective PREMAG trial. Gynecol Obstet Fertil 36:278\u2013288","journal-title":"Gynecol Obstet Fertil"},{"key":"3581_CR7","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-0528.2006.01162.x","volume":"114","author":"S Marret","year":"2007","unstructured":"Marret S, Marpeau L, Zupan-Simunek V (2007) Magnesium sulfate given before very-preterm birth to protect the infant brain: the randomized controlled PREMAG trial. BJOG 114:310\u2013318","journal-title":"BJOG"},{"key":"3581_CR8","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1001\/jama.290.20.2669","volume":"290","author":"CA Crowther","year":"2003","unstructured":"Crowther CA, Hiller JE, Doyle LW, Haslam RR (2003) Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA 290:2669\u20132676","journal-title":"JAMA"},{"key":"3581_CR9","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa0801187","volume":"359","author":"DJ Rouse","year":"2008","unstructured":"Rouse DJ, Hirtz DG, Thom E (2008) A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 359:895\u2013905","journal-title":"N Engl J Med"},{"issue":"9321","key":"3581_CR10","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(02)08778-0","volume":"359","author":"D Altman","year":"2002","unstructured":"Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, Smith D, Magpie Trial Collaboration Group (2002) Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie trial: a randomized placebo-controlled trial. Lancet 359(9321):1877\u20131890","journal-title":"Lancet"},{"key":"3581_CR11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1471-0528.2006.01165.x","volume":"114","author":"Magpie Trial Follow-up Study Collaborative Group","year":"2007","unstructured":"Magpie Trial Follow-up Study Collaborative Group (2007) The Magpie trial : a randomized trial comparing magnesium sulfate with placebo for pre-eclampsia; outcome for children at 18 months. BJOG 114:289\u2013299","journal-title":"BJOG"},{"key":"3581_CR12","first-page":"CD004661","volume":"1","author":"LW Doyle","year":"2009","unstructured":"Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D (2009) Magnesium sulfate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 1:CD004661","journal-title":"Cochrane Database Syst Rev"},{"key":"3581_CR13","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/AOG.0b013e3181a60495","volume":"113","author":"LW Doyle","year":"2009","unstructured":"Doyle LW, Crowther CA, Middleton P, Marret S (2009) Antenatal magnesium sulfate and neurologic outcome in preterm infants: a systematic review. Obstet Gynecol 113:1327\u20131333","journal-title":"Obstet Gynecol"},{"key":"3581_CR14","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ajog.2009.04.005","volume":"200","author":"A Conde-Agudelo","year":"2009","unstructured":"Conde-Agudelo A, Romero R (2009) Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34\u00a0weeks gestation: a systematic review and metaanalysis. Am J Obstet Gynecol 200:595\u2013609","journal-title":"Am J Obstet Gynecol"},{"key":"3581_CR15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/AOG.0b013e3181ae98c2","volume":"114","author":"MM Constantine","year":"2009","unstructured":"Constantine MM, Weiner SJ (2009) Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis. Obstet Gynecol 114:354\u2013364","journal-title":"Obstet Gynecol"},{"issue":"1","key":"3581_CR16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2046-4053-1-21","volume":"21","author":"The AMICABLE Group","year":"2012","unstructured":"The AMICABLE Group (2012) Antenatal magnesium individual participant data international collaboration: assessing the benefits for babies using the best level of evidence (AMICABLE). Syst Rev 21(1):21","journal-title":"Syst Rev"},{"key":"3581_CR17","first-page":"CD009395","volume":"2","author":"TM Nguyen","year":"2013","unstructured":"Nguyen TM, Crowther CA, Wilkinson D, Bain E (2013) Magnesium sulfate for women at term for neuroprotection of the fetus. Cochrane Database Syst Rev 2:CD009395. doi: 10.1002\/14651858.CD009395.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"3581_CR18","author":"CA Crowther","year":"2013","unstructured":"Crowther CA, Middleton PF, Wilkinson D, Ashwood P, Haslam R, MAGENTA Study Group (2013) Magnesium sulfate at 30 to 34\u00a0weeks\u2019 gestational age: neuroprotection trial (MAGENTA) study protocol. BMC Pregnancy Childbirth. doi: 10.1186\/1471-2393-13-91","journal-title":"BMC Pregnancy Childbirth"},{"key":"3581_CR19","first-page":"122","volume":"22","author":"A Cahill","year":"2010","unstructured":"Cahill A, Stout M, Caughey A (2010) Intrapartum magnesium for prevention of cerebral palsy: continuing controversy ? Obstet Gynecol 22:122\u2013127","journal-title":"Obstet Gynecol"},{"key":"3581_CR20","volume-title":"Antenatal magnesium sulfate prior to preterm birth for neuroprotection of the fetus, infant and child: National clinical practice guideline","author":"The Antenatal Magnesium Sulfate for Neuroprotection Guideline Development panel","year":"2010","unstructured":"The Antenatal Magnesium Sulfate for Neuroprotection Guideline Development panel (2010) Antenatal magnesium sulfate prior to preterm birth for neuroprotection of the fetus, infant and child: National clinical practice guideline. The University of Adelaide, Adelaide"},{"key":"3581_CR21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/GCO.0b013e3283372312","volume":"22","author":"AG Cahill","year":"2010","unstructured":"Cahill AG, Stout MJ, Caughey AB (2010) Intrapartum magnesium for prevention of cerebral palsy: continuing controversy? Curr Opin Obstet Gynecol 22:122\u2013127","journal-title":"Curr Opin Obstet Gynecol"},{"key":"3581_CR22","first-page":"CD009302","volume":"2","author":"E Bain","year":"2012","unstructured":"Bain E, Middleton P, Crowther CA (2012) Different magnesium sulfate regimens for neuroprotection of the fetus for women at risk for preterm birth. Cohrane Database Syst Rev 2:CD009302","journal-title":"Cohrane Database Syst Rev"},{"issue":"5","key":"3581_CR23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/1471-0528.12535","volume":"121","author":"ES Bain","year":"2014","unstructured":"Bain ES, Middleton PF, Yelland LN, Ashwood PJ, Crowther CA (2014) Maternal adverse effects with different loading infusions rates of antenatal magnesium sulphate for preterm fetal neuroprotection: the IRIS randomized trial. BJOG 121(5):595\u2013603. doi: 10.1111\/1471-0528.12535","journal-title":"BJOG"},{"key":"3581_CR24","author":"H Suzuki-Kakisaka","year":"2013","unstructured":"Suzuki-Kakisaka H, Sugimoto J, Tetarbe M, Romani AM, Ramirez Kithcen CM, Bernstein HB (2013) Magnesium sulfate increases intracellular magnesium reducing inflammatory cytokine release in neonates. AJRI. doi: 10.1111\/aji.12118","journal-title":"AJRI"},{"key":"3581_CR25","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.4049\/jimmunol.1101765","volume":"188","author":"J Sugimoto","year":"2012","unstructured":"Sugimoto J, Romani AM, Valentin-Torres AM, Luciano AA, Ramirez Kitchen CM, Funderburg N, Mesiano S, Bernstein HB (2012) Magnesium decreases inflammatory cytokine production: a novel innate immunomodulatory mechanism. J Immunom 188:6338\u20136346","journal-title":"J Immunom"},{"key":"3581_CR26","author":"JL Cross","year":"2010","unstructured":"Cross JL, Meloni BP, Bakker AJ, Lee S, Knuckey NW (2010) Modes of neuronal calcium entry and homeostasis following cerebral ischemia. Stroke Res Treat. doi: 10.4061\/2010\/316862","journal-title":"Stroke Res Treat"},{"key":"3581_CR27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2040-7378-5-6","volume":"5","author":"Th Westermaier","year":"2013","unstructured":"Westermaier Th, Stetter Ch, Kunze E, Willner N, Raslan F, Vince GH, Ernestus RI (2013) Magnesium treatment for neuroprotection in ischemic diseases of the brain. Exp Transl Stroke Med 5:6","journal-title":"Exp Transl Stroke Med"},{"issue":"5","key":"3581_CR28","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1447-0756.2011.01806.x","volume":"38","author":"S Dasgupta","year":"2012","unstructured":"Dasgupta S, Ghosh D, Seal SL, Kamilya G, Karmakar M, Saha D (2012) Randomized controlled study comparing effect of magnesium sulfate with placebo on fetal umbilical artery and middle cerebral artery blood flow in mild preeclampsia at \u226534\u00a0weeks gestational age. J Obstet Gynaecol Res 38(5):763\u2013771","journal-title":"J Obstet Gynaecol Res"},{"issue":"5","key":"3581_CR29","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3109\/14767058.2011.584087","volume":"25","author":"E Rhee","year":"2012","unstructured":"Rhee E, Beiswenger T, Oguejiofor CE, James AH (2012) The effects of magnesium sulfate on maternal and fetal platelet aggregation. J Matern Fetal Neonatal Med 25(5):478\u2013483","journal-title":"J Matern Fetal Neonatal Med"},{"key":"3581_CR30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1071-5576(01)00161-7","volume":"9","author":"Y Garnier","year":"2002","unstructured":"Garnier Y, Middelanis J, Jensen A, Berger R (2002) Neuroprotective effects of magnesium on metabolic disturbances in fetal hippocampal slices after oxygen\u2013glucose deprivation: mediation by nitric oxide system. J Soc Gynecol Invest 9:86\u201392","journal-title":"J Soc Gynecol Invest"},{"key":"3581_CR31","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000146536.68208.84","volume":"44","author":"T Shimosawa","year":"2004","unstructured":"Shimosawa T, Takano K, Ando K, Fujita T (2004) Magnesium inhibits norepinephrine release by blocking N-type calcium channels at peripheral nerve endings. Hypertenssion 44:897\u2013902","journal-title":"Hypertenssion"},{"key":"3581_CR32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1471-0528.1994.tb13126.x","volume":"101","author":"M Ben Ami","year":"1994","unstructured":"Ben Ami M, Giladi Y, Shalev E (1994) The combination of magnesium sulfate and Nifedipine: a cause of neuromuscular blockade. Br J Obstet Gynecol 101:262\u2013263","journal-title":"Br J Obstet Gynecol"},{"key":"3581_CR33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ajog.2004.11.059","volume":"193","author":"LA Magee","year":"2005","unstructured":"Magee LA, Miremadi S, Li J (2005) Therapy with both magnesium sulfate and Nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. Am J Obstet Gynecol 193:153\u2013163","journal-title":"Am J Obstet Gynecol"},{"key":"3581_CR34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0002-9378(89)90226-3","volume":"161","author":"SW Snyder","year":"1989","unstructured":"Snyder SW, Cardwell MS (1989) Neuromuscular blockade with magnesium-sulfate and Nifedipine. Am J Obstet Gynecol 161:35\u201336","journal-title":"Am J Obstet Gynecol"},{"key":"3581_CR35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.earlhumdev.2013.02.001","volume":"89","author":"SY Kim","year":"2013","unstructured":"Kim SY, El-Dib M, Ahmad T, Aly H (2013) Baseline serum magnesium concentrations and neurodevelopmental outcomes of extremely low birth weight premature infants. Early Human Dev 89:239\u2013242","journal-title":"Early Human Dev"},{"key":"3581_CR36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/sj.jp.7211419","volume":"26","author":"R Mittendorf","year":"2006","unstructured":"Mittendorf R, Damman O, Lee KS (2006) Brain lesions in newborns exposed to high-dose magnesium sulfate during preterm labor. J Perinatol 26:57\u201363","journal-title":"J Perinatol"},{"key":"3581_CR37","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0029-7844(98)00163-X","volume":"92","author":"R Mittendorf","year":"1998","unstructured":"Mittendorf R, Pryde P, Khoshnood B, Lee KS (1998) If tocolytic magnesium sulfate is associated with excess total pediatric mortality, what is its impact? Obstet Gynecol 92:308\u2013311","journal-title":"Obstet Gynecol"},{"key":"3581_CR38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1515\/jpm.2011.036","volume":"39","author":"PG Pryde","year":"2011","unstructured":"Pryde PG, Mittendorf R (2011) Using prophylactic, but not tocolytic, magnesium sulfate to reduce cerebral palsy related to prematurity: what dose, and what about infant mortality? J Perinat Med 39:375\u2013378","journal-title":"J Perinat Med"},{"key":"3581_CR39","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1055\/s-0032-1316440","volume":"29","author":"M Abbassi-Ghanavati","year":"2012","unstructured":"Abbassi-Ghanavati M, Alexander JM, McIntire DD, Savani RC, Leveno KJ (2012) Neonatal effects of magnesium sulfate given to the mother. Am J Perinatol 29:795\u2013799","journal-title":"Am J Perinatol"},{"key":"3581_CR40","unstructured":"Food and Drug Administration (2013) FDA recommends against prolonged use of magnesium to stop pre-term labor due to bone changes in exposed babies. FDA Drug Safety Communication. Silver Spring (MD). http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM353335.pdf . Accessed 10 July 2014"},{"key":"3581_CR41","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/AOG.0b013e3181d4ffa5","volume":"115","author":"ACOG Committee on Obstetric Practice","year":"2010","unstructured":"ACOG Committee on Obstetric Practice (2010) Society for Maternal-Fetal Medicine. Committee opinion No 455: Magnesium before anticipated preterm birth for neuroprotection. Obstet Gynecol 115:669\u2013671","journal-title":"Obstet Gynecol"},{"key":"3581_CR42","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/01.AOG.0000433994.46087.85","volume":"122","author":"ACOG Committee Opinion No","year":"2013","unstructured":"ACOG Committee Opinion No (2013) 573 Magnesium Sulfate Use in Obstetrics. Obstet Gynecol 122:727\u2013728","journal-title":"Obstet Gynecol"},{"key":"3581_CR43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.earlhumdev.2010.02.007","volume":"86","author":"K Yokoyama","year":"2010","unstructured":"Yokoyama K, Takahashi N, Yada Y (2010) Prolonged maternal magnesium administration and bone metabolism in neonates. Early Hum Dev 86:187\u2013191","journal-title":"Early Hum Dev"},{"key":"3581_CR44","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/sj.jp.7211508","volume":"26","author":"KE Wedig","year":"2006","unstructured":"Wedig KE, Kogan J, Schorry EK (2006) Skeletal demineralization and fractures caused by fetal magnesium toxicity. J Perinatol 26:371\u2013374","journal-title":"J Perinatol"},{"key":"3581_CR45","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/aogs.12021","volume":"91","author":"J Brok","year":"2012","unstructured":"Brok J, Huusom LD, Thorlund K (2012) Conclusive meta-analyses on antenatal magnesium may be inconclusive! Are we underestimating the risk of random error? Acta Obstet Gynecol Scand 91:1247\u20131251","journal-title":"Acta Obstet Gynecol Scand"},{"key":"3581_CR46","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/aogs.12018","volume":"91","author":"LD Huusom","year":"2012","unstructured":"Huusom LD, Brok J, Hegaard HK, Pryds O, Secher NJ (2012) Does antenatal magnesium suplhate prevent cerebral palsy in preterm infants? The final trial? Acta Obstet Gynecol Scand 91:1346\u20131347","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5","key":"3581_CR47","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1701-2163(16)34886-1","volume":"33","author":"L Magee","year":"2011","unstructured":"Magee L, Sawchuck D, Synnes A, von Dadelszen P (2011) SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection. J Obstet Gynaecol Can 33(5):516\u2013529","journal-title":"J Obstet Gynaecol Can"},{"key":"3581_CR48","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1479-828X.2012.01434.x","volume":"52","author":"LL Ow","year":"2012","unstructured":"Ow LL, Kennedy A, McCarthy EA, Walker SP (2012) Feasability of implementing magnesium sulphate for neuroprotection in a tertiary obstetric unit. Aust N Z J Obstet Gynaeol 52:356\u2013360","journal-title":"Aust N Z J Obstet Gynaeol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-014-3581-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-014-3581-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-014-3581-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T06:17:11Z","timestamp":1650781031000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-014-3581-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,12]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["3581"],"URL":"https:\/\/doi.org\/10.1007\/s00404-014-3581-1","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,12]]}}}